Funding for this research was provided by:
canadian cancer society
lantheus medical imaging
Received: 26 November 2021
Accepted: 9 February 2022
First Online: 8 March 2022
: This study is centrally approved by the Quebec Multicentric Ethics Committee at the sponsor site (CHUM – approval number MP-02-2021-9258). Individual study participants will provide written informed consent to participate in the study. A sample consent form is available in Appendix InternalRef removed.
: Not applicable.
: KZ is a consultant for: Invicro, General Electric, Jubilant DraxImage and the Centre for Probe Development and Commercialization.